LCN2 and inflammatory breast carcinoma: Although Lcn-2 CRISPR knock-out TNBC cells did not show a difference in cell proliferation, siRNA-mediated Lcn-2 silencing in IBC cells significantly reduced their viability, invasion, proliferation, and migration [145].